e-learning
resources
Barcelona 2010
Wednesday, 22.09.2010
Novel cellular mechanisms in lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Anti-proliferative and anti-inflammatory effect of glucocorticoids in nasal mucosa and nasal polyp fibroblasts
L. Pujols, M. Fuentes, L. Fernández-Bertolín, I. Alobid, J. Roca-Ferrer, J. Mullol, C. Picado (Barcelona, Spain)
Source:
Annual Congress 2010 - Novel cellular mechanisms in lung disease
Session:
Novel cellular mechanisms in lung disease
Session type:
E-Communication Session
Number:
5684
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Pujols, M. Fuentes, L. Fernández-Bertolín, I. Alobid, J. Roca-Ferrer, J. Mullol, C. Picado (Barcelona, Spain). Anti-proliferative and anti-inflammatory effect of glucocorticoids in nasal mucosa and nasal polyp fibroblasts. Eur Respir J 2010; 36: Suppl. 54, 5684
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
The antiinflammatory effect of statins on human bronchial epithelial cells
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010
The antiinflammatory effect of statins on human bronchial epithelial cells
Source: Annual Congress 2008 - Airway cell biology
Year: 2008
Inhibitory effects of montelukast on mediator release by nasal epithelial cells from asthmatic subjects
Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Year: 2013
Mechanisms responsible for glucocorticoid insensitivity in nasal mucosa and nasal polyps
Source: Annual Congress 2010 - COPD and asthma: models and human studies
Year: 2010
HDAC2-independent anti-inflammatory effects of budesonide in human lung fibroblasts
Source: Annual Congress 2011 - Recent developments in COPD
Year: 2011
Anti-inflammatory and anti-oxidative activity of YPL-001 in human bronchial epithelial cells
Source: International Congress 2017 – Cigarette smoke and particulate matter: basic science and clinical aspects
Year: 2017
Effects of TNF-alpha on the human nasal mucosa
in vivo
Source: Eur Respir J 2006; 28: Suppl. 50, 672s
Year: 2006
Cox-2 regulation by IL-1β through MAPKs: A comparison of nasal mucosa and nasal polyps fibroblasts from AIA patients
Source: Annual Congress 2010 - COPD and asthma: models and human studies
Year: 2010
Glucocorticoid therapy increases COX-2 gene expression in nasal polyps in vivo
Source: Eur Respir J 2009; 33: 502-508
Year: 2009
Inhibitory effect of naringenin in airway mucus hypersecretion and the possible mechanism
Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes
Year: 2018
Modulatory effects of immunosuppressives on IL-8 and GM-CSF expression in bronchial and alveolar epithelial cells
Source: Eur Respir J 2006; 28: Suppl. 50, 854s
Year: 2006
Intranasal steroids decrease eosinophils but not mucin expression in nasal polyps
Source: Eur Respir J 2004; 24 : 594-600
Year: 2004
Effect of additional PBMC on bacterial-induced mucus expression in explanted human airway mucosa
Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation
Year: 2010
Synergistic anti-inflammatory effects of salmeterol and fluticasone on the release of IL-8 and MCP-1 by human bronchial epithelial cells
Source: Eur Respir J 2003; 22: Suppl. 45, 39s
Year: 2003
Inflammatory and antioxidant effects of inhaled nanoparticles on human primary bronchial epithelial cells
Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling
Year: 2019
Anti-inflammatory efficacy of formoterol via transrepressive mechanisms is independent of the glucocorticoid receptor in human bronchial epithelial cells
Source: Eur Respir J 2004; 24: Suppl. 48, 128s
Year: 2004
Effect of cigarette smoke extract on Th17 inflammation and the anti-inflammatory effect of glucocorticoids in human airway smooth muscle cells
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021
The effect of Taxane anticancer drugs on bronchiolar ciliary activity in human airway cultured cells
Source: Virtual Congress 2020 – Respiratory homeostasis and structural changes in disease
Year: 2020
NOTCH-1 activation sustains hyperexpression of IL-33 in the epithelium of nasal polyps
Source: International Congress 2017 – Systemic and airway biomarkers
Year: 2017
Over-expression of Th17-related cytokines in bronchial and nasal submucosa in severe asthma
Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept